Table 1. Disease, therapy, and previous... | American Society of Hematology

Table 1.

Disease, therapy, and previous alloimmunization exposure of patients receiving platelet transfusions for thrombocytopenia

	Treatment group, no. (%)
	Test (n = 52)	Reference (n = 51)
Primary diagnosis
Acute leukemia	26 (50)	24 (47)
Hematopoietic tumor^*/nonhematopoietic solid tumor	21 (40)	19 (37)
Other	5 (10)	8 (16)
Therapy
Bone marrow transplantation	2 (4)	1 (2)
Peripheral blood stem cell transplantation	17 (33)	18 (35)
Chemotherapy	33 (63)	32 (63)
Alloimmunization exposure^†	46 (88)	44 (86)

	Treatment group, no. (%)
	Test (n = 52)	Reference (n = 51)
Primary diagnosis
Acute leukemia	26 (50)	24 (47)
Hematopoietic tumor^*/nonhematopoietic solid tumor	21 (40)	19 (37)
Other	5 (10)	8 (16)
Therapy
Bone marrow transplantation	2 (4)	1 (2)
Peripheral blood stem cell transplantation	17 (33)	18 (35)
Chemotherapy	33 (63)	32 (63)
Alloimmunization exposure^†	46 (88)	44 (86)

There were no statistical differences between groups(P > .05).

Includes multiple myeloma, lymphoma, and Hodgkin lymphoma.

Previous platelet or red blood cell transfusion or, for women, previous pregnancy.